SCHEMBL25669502

SCHEMBL25669502

CCOC(=O)C(NC(C)=O)P(=O)(OC)OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ ALOX15 P16050 2/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ PLA2G2A P14555 4/20 0.36
▸ LMNA P02545 3/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ MGAM O43451 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ SI P14410 1/20 0.34
▸ MGAM2 Q2M2H8 1/20 0.34
▸ SOAT1 P35610 1/20 0.34
▸ CHRM1 P11229 1/20 0.34
▸ ADORA1 P30542 1/20 0.34
▸ MAPT P10636 1/20 0.33
▸ CAD P27708 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL712601 0.85 SMN1; SMN2 (0.33) ALDH1A1CYP2C19PLA2G2ALMNACA12
SCHEMBL12903917 0.81 CYP2D6 (0.44) ALDH1A1CYP3A4ALOX15CYP2D6CYP2C9
SCHEMBL13799012 0.80 PLA2G2A (0.37) ALDH1A1CYP2C19TSHRPLA2G2ALMNA
SCHEMBL5877427 0.79 CYP1A2 (0.50) ALDH1A1CYP2D6CYP2C9CYP2C19GAA
SCHEMBL4860398 0.79 LMNA (0.34) ALDH1A1CYP2C19PLA2G2ALMNACA12
SCHEMBL9304618 0.79 CYP3A4 (0.41) ALDH1A1CYP3A4CYP2C9CYP2C19PLA2G2A
SCHEMBL5231692 0.77 KDM4E (0.36) ALDH1A1ALOX15CYP2C19TDP1PLA2G2A
SCHEMBL14601302 0.72 ALDH1A1 (0.46) ALDH1A1ALOX15CYP2D6CYP2C9CYP2C19
SCHEMBL8837118 0.72 ALDH1A1 (0.46) ALDH1A1ALOX15CYP2D6CYP2C9CYP2C19
SCHEMBL4421264 0.71 ALDH1A1 (0.43) ALDH1A1CYP3A4ALOX15CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183180-A1 PROCESS OF MAKING ROXADUSTAT SUZHOU PENGXU PHARMATECH CO., LTD. (CN) 2023-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183180-A1 PROCESS OF MAKING ROXADUSTAT CYP2B6, UGT1A6, CYP2D6 ALDH1A1 752/4885CYP3A4 15/4885ALOX15 302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback